ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Seffalair® Spiromax®, Multidosen-Pulverinhalator:Teva Pharma AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Packungen

Seffalair Spiromax 55/14: Multidosen-Pulverinhalator zu 60 Inhalationen zu je 14 μg Salmeterol und 55 μg Fluticason-propionat, B.
Seffalair Spiromax 113/14: Multidosen-Pulverinhalator zu 60 Inhalationen zu je 14 μg Salmeterol und 113 μg Fluticason-propionat, B.
Seffalair Spiromax 232/14: Multidosen-Pulverinhalator zu 60 Inhalationen zu je 14 μg Salmeterol und 232 μg Fluticason-propionat, B.

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home